VivoSeq
Other

PET/CT Imaging

0

Pipeline Programs↗

14

Active Trials↗

2

Companies Involved↗

PET/CT Imaging is an early-stage landscape with 0 programs across 2 companies. The most active players are Telix Pharmaceuticals (Innovations) Pty Limited, GSK.

Intelligence

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

3/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Telix Pharmaceuticals (Innovations) Pty Limited

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

31

clinical trials

Recruiting9 · 29%
Completed8 · 26%
Unknown status7 · 23%
Not yet recruiting3 · 10%
Active, not recruiting2 · 6%
Terminated1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

31 trials

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
Recruiting·TTelix Pharmaceuticals (Innovations) Pty Limited·Phase 3·NCT06750419·82 enrolled
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Recruiting·LLeiden University Medical Center·N/A·NCT05685836·15 enrolled
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
Recruiting·UUniversity of Pennsylvania·N/A·NCT05658913·100 enrolled
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Recruiting·PPeking Union Medical College Hospital·Phase 1·NCT05549024·90 enrolled
68Ga-P3 PET/CT Imaging in Prostate
Recruiting·PPeking University First Hospital·N/A·NCT05940259·30 enrolled
68Ga-N188 PET/CT Imaging in Malignancy
Recruiting·PPeking University First Hospital·N/A·NCT05593107·203 enrolled
68Ga-P3 PET/CT Imaging in Malignancy
Recruiting·PPeking University First Hospital·N/A·NCT05887687·350 enrolled
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
Recruiting·UUniversity of Pennsylvania·Phase 1·NCT04263792·20 enrolled
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Recruiting·PPeking Union Medical College Hospital·Phase 1/2·NCT07464132·30 enrolled
EXPLORER Total Body PET/CT Imaging for Myofascial Pain
Active, not recruiting·UUniversity of California, Davis·Phase 1·NCT05876858·53 enrolled
Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis
Active, not recruiting·FFutureChem·Phase 3·NCT05004285·398 enrolled
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
Not yet recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2/3·NCT07444723·193 enrolled
68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy
Not yet recruiting·PPeking University Cancer Hospital & Institute·N/A·NCT06716788·50 enrolled
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
Not yet recruiting·—·Phase 1·NCT07144085·80 enrolled
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
Completed·UUniversity of Pennsylvania·Phase 1·NCT03424525·16 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)